Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1265620

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1265620

Neglected Tropical Diseases Diagnosis

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neglected Tropical Diseases Diagnosis Market to Reach $10.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neglected Tropical Diseases Diagnosis estimated at US$5.5 Billion in the year 2022, is projected to reach a revised size of US$10.3 Billion by 2030, growing at aCAGR of 8% over the period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Molecular / Modern segment is readjusted to a revised 9.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 11.7% CAGR

The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics., Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix
Show more
Product Code: MCP22362

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Neglected Tropical Diseases Diagnosis - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular / Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular / Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular / Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Centralized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Centralized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Centralized by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Point of Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Point of Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Point of Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Clinical Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Clinical Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Neglected Tropical Diseases Diagnosis Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • JAPAN
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • CHINA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • EUROPE
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • FRANCE
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • GERMANY
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • INDIA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: India 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: India 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: India 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030
  • AFRICA
    • Neglected Tropical Diseases Diagnosis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Neglected Tropical Diseases Diagnosis by Method - Conventional and Molecular / Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Method - Percentage Breakdown of Value Sales for Conventional and Molecular / Modern for the Years 2014, 2023 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Neglected Tropical Diseases Diagnosis by Service Type - Centralized and Point of Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Neglected Tropical Diseases Diagnosis by Service Type - Percentage Breakdown of Value Sales for Centralized and Point of Care for the Years 2014, 2023 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Neglected Tropical Diseases Diagnosis by End-Use - Clinical Labs, Hospitals & Clinics and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Neglected Tropical Diseases Diagnosis by End-Use - Percentage Breakdown of Value Sales for Clinical Labs, Hospitals & Clinics and Home Healthcare for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!